Pharvaris falls as Q4 loss widens

Pharvaris NV

05/04/2023 19:35

** Shares of Switzerland-based drug developer Pharvaris NV
 PHVS.O  down 5.8% at $8
    ** Co's Q4 loss widens to 1.16 euros per share from 0.37
euro per share a year earlier
    ** R&D expenses in the quarter up to 15.7 mln euros from
10.7 mln euros 
    ** G&A expenses rise to 7.8 mln euros from 5.5 mln euros
    ** Cash and cash equivalents were 162 mln euros as of Dec.
31, 2022, vs 209 mln euros a year earlier
    ** PHVS down about 28.9% YTD 

 (Reporting by Vaibhav Sadhamta in Bengaluru)
 ((Vaibhav.sadhamta@thomsonreuters.com))